ArticleMolecular cancer therapeutics2020

LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia.

Yasuaki Anami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.